EcoDrugPlus

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSPLOG00000019077
Gene Symbol: AKR1B1
4 Cross references
427 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSPLOG00000022452
Gene Symbol: GAA
4 Cross references
234 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSPLOG00000001671
Gene Symbol: AOC1
2 Cross references
230 Possible Orthologues:

Amylase Alpha 2b

Ensembl ID : ENSPLOG00000010120
Gene Symbol: AMY2B
3 Cross references
213 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSPLOG00000019684
Gene Symbol: APCS
2 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSPLOG00000018974
Gene Symbol: APP
4 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSPLOG00000022591
Gene Symbol: AR
2 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSPLOG00000018350
Gene Symbol: ACE
4 Cross references
93 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSPLOG00000017325
Gene Symbol: AGTR1
2 Cross references
207 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSPLOG00000021782
Gene Symbol: AGTR2
2 Cross references
191 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSPLOG00000009836
Gene Symbol: APLNR
4 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSPLOG00000018596
Gene Symbol: APH1A
4 Cross references
137 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).